SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.3500
+0.0150 (4.48%)
Sep 16, 2026, 2:50 PM AEST
SomnoMed Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 114.53 | 114.53 | 111.49 | 91.65 | 83.62 | 72.58 |
Revenue Growth | -3.35% | 2.73% | 21.65% | 9.61% | 15.20% | 15.75% |
Gross Profit Gross Profit Growth | 70.02 | 70.02 | 66.73 | 55.13 | 51.92 | 44.28 |
Operating Income Operating Income Growth | 0.98 | 0.98 | -0.31 | -8.33 | -3.6 | -4.13 |
Net Income Net Income Growth | -2.65 | -2.65 | -3.46 | -12.24 | -8 | -4.44 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.02 | -0.10 | -0.10 | -0.06 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Europe Europe Growth | 63.51 | 63.51 | 62.7 | 54.17 | 48.89 | 43.52 |
Intersegment Eliminations Intersegment Eliminations Growth | -21.38 | -21.38 | -20.67 | -17.21 | -13.77 | -11.22 |
Asia Pacific Asia Pacific Growth | 26.47 | 26.47 | 26.23 | 21.74 | 18.16 | 15.45 |
North America (Excl. North America (RSS Component)) North America (Excl. North America (RSS Component)) Growth | 45.94 | 45.94 | 43.23 | 32.94 | 30.33 | 24.83 |
Total Total Growth | 114.53 | 114.53 | 111.49 | 91.65 | 83.62 | 72.58 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 17.18 | 17.18 | 17.29 | 16.18 | 11.96 | 15.64 |
Total Debt Total Debt Growth | 5.46 | 5.46 | 8.03 | 6.72 | 23.51 | 12.01 |
Net Cash (Debt) Net Cash Growth | 11.73 | 11.73 | 9.27 | 9.46 | -11.55 | 3.63 |
Net Cash Growth | 2.72% | 26.53% | -2.03% | - | - | -70.22% |
Net Cash Per Share Net Cash Per Share Growth | 0.05 | 0.05 | 0.04 | 0.08 | -0.15 | 0.05 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 8.28 | 8.28 | 7.78 | -6.03 | -3.88 | 1.86 |
Capital Expenditures CapEx Growth | -3.26 | -3.26 | -2.42 | -1.39 | -3.14 | -1.01 |
Free Cash Flow Free Cash Flow Growth | 5.02 | 5.02 | 5.36 | -7.42 | -7.02 | 0.85 |
Free Cash Flow Growth | 35.39% | -6.45% | - | - | - | 53.94% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 61.13% | 61.13% | 59.85% | 60.15% | 62.09% | 61.01% |
Operating Margin | 0.85% | 0.85% | -0.28% | -9.09% | -4.31% | -5.69% |
Pretax Margin | -0.40% | -0.40% | -0.69% | -12.30% | -8.43% | -4.82% |
Profit Margin | -2.31% | -2.31% | -3.10% | -13.36% | -9.57% | -6.11% |
FCF Margin | 4.38% | 4.38% | 4.81% | -8.10% | -8.39% | 1.17% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Forward PE | 17.89 | 20.31 | 108.33 | 84.02 | 85.27 | 175.36 |
P/FCF Ratio | 15.33 | 22.71 | 26.19 | - | - | 117.89 |
PS Ratio | 0.67 | 1.00 | 1.26 | 0.60 | 0.95 | 1.38 |